Pressmeddelanden från Clinical Laserthermia

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Clinical Laserthermia

Clinical Laserthermia Systems AB publishes Year-end report January – December 2025 20 feb 08:45

Clinical Laserthermia

CLS publicerar Bokslutskommuniké januari – december 2025 08 jan 08:30

Clinical Laserthermia

TRANBERG[®] Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands 12 dec 2025 21:00

Clinical Laserthermia

CLS initiates recruitment process for permanent Chief Financial Officer 03 dec 2025 08:30

Clinical Laserthermia

Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prism[®][ ]branded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery 14 nov 2025 08:30

Clinical Laserthermia

CLS Publishes Interim Report January – September 2025 14 nov 2025 08:30

Clinical Laserthermia

CLS publicerar delårsrapport januari – september 2025 07 okt 2025 22:15

Clinical Laserthermia

CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results 30 sep 2025 13:35

Clinical Laserthermia

Clinical Laserthermia Systems AB tillförs 20,9 MSEK genom fullteckning av teckningsoptioner av serie TO 8 B 30 sep 2025 13:35

Clinical Laserthermia

Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B 04 sep 2025 17:00

Clinical Laserthermia

Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT 22 aug 2025 08:30

Clinical Laserthermia

CLS publishes half-year report January – June 2025 22 aug 2025 08:30

Clinical Laserthermia

CLS publicerar halvårsrapport januari – juni 2025 27 jun 2025 16:35

Clinical Laserthermia

Communique from the Annual General Meeting on Friday June 27th in Clinical Laserthermia Systems A 27 jun 2025 16:35

Clinical Laserthermia

Kommuniké från årsstämma fredagen den 27 juni i Clinical Laserthermia Systems AB 06 jun 2025 21:00

Clinical Laserthermia

Clinical Laserthermia Systems publishes annual report for 2024 06 jun 2025 21:00

Clinical Laserthermia

Clinical Laserthermia Systems publicerar årsredovisningen för 2024 27 maj 2025 11:00

Clinical Laserthermia

Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 27, 2025 27 maj 2025 11:00

Clinical Laserthermia

Kallelse till årsstämma i Clinical Laserthermia Systems AB den 27 juni 2025 16 maj 2025 08:30

Clinical Laserthermia

Clinical Laserthermia Systems AB publicerar Delårsrapport för januari – mars 2025 16 maj 2025 08:30

Clinical Laserthermia

Clinical Laserthermia Systems AB publishes Interim report for January – March 2025 28 apr 2025 08:30

Clinical Laserthermia

Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance 15 apr 2025 08:30

Clinical Laserthermia

Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis 09 apr 2025 16:56

Clinical Laserthermia

BioStock: CLS not significantly affected by tariffs 09 apr 2025 16:56

Clinical Laserthermia

BioStock: CLS påverkas inte nämnvärt av tullarna 08 apr 2025 13:45

Clinical Laserthermia

Proposed U.S. tariffs expected to have minimal impact on CLS business 27 feb 2025 12:16

Clinical Laserthermia

BioStock: CLS raises up to 37 MSEK through directed share issue 27 feb 2025 12:16

Clinical Laserthermia

BioStock: CLS tar in upp till 37 Mkr genom riktad emission 27 feb 2025 08:55

Clinical Laserthermia

Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion 27 feb 2025 08:55

Clinical Laserthermia

Clinical Laserthermia Systems AB tillförs upp till 37 MSEK genom en riktad emission för accelererad kommersialisering och expansion 25 feb 2025 12:14

Clinical Laserthermia

BioStock: CLS fortsätter mot målet att bli kassapositiva 2026 25 feb 2025 12:14

Clinical Laserthermia

BioStock: CLS continues toward the goal of becoming cash flow positive by 2026 21 feb 2025 08:30

Clinical Laserthermia

Clinical Laserthermia Systems AB publicerar Bokslutskommuniké januari – december 2024 21 feb 2025 08:30

Clinical Laserthermia

Clinical Laserthermia Systems AB publishes Year-end report January – December 2024 10 feb 2025 16:16

Clinical Laserthermia

BioStock: CLS presents study results and board changes 10 feb 2025 16:16

Clinical Laserthermia

BioStock: Studieresultat och förändringar i styrelsen för CLS 07 feb 2025 15:50

Clinical Laserthermia

CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request 07 feb 2025 15:50

Clinical Laserthermia

CLS medgrundare och förre VD Lars-Erik Eriksson lämnar styrelsen på egen begäran 30 jan 2025 10:00

Clinical Laserthermia

Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published 16 jan 2025 14:11

Clinical Laserthermia

BioStock: CLS predicts continued growth in 2025–2026 16 jan 2025 14:11

Clinical Laserthermia

BioStock: CLS prognos visar på fortsatt tillväxt 2025–2026 14 jan 2025 08:50

Clinical Laserthermia

CLS Recaps 2024 and Provides Outlook for 2025-26 09 dec 2024 15:20

Clinical Laserthermia

The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024.09 dec 2024 15:20

Clinical Laserthermia

Valberedningen i Clinical Laserthermia Systems AB har utsetts i enlighet med riktlinjer för valberedning som antogs på årsstämman den 28 juni 2024.02 dec 2024 11:30

Clinical Laserthermia

CLS carries out a directed issue to guarantors in connection with completed exercise of warrants 02 dec 2024 11:30

Clinical Laserthermia

CLS genomför riktad nyemission av aktier till garanter i samband med genomförd Optionsinlösen 26 nov 2024 12:50

Clinical Laserthermia

CLS tillförs 22,4 MSEK genom nyttjandet av teckningsoptioner av serie TO 7 B samt beslutar om riktad nyemission 26 nov 2024 12:50

Clinical Laserthermia

CLS receives SEK 22.4 million through the exercise of warrants of series TO 7 B and decides on a directed issue 13 nov 2024 08:30

Clinical Laserthermia

CLS receives additional guarantee commitments of approximately SEK 5.8 million for warrants of series TO 7 B 13 nov 2024 08:30

Clinical Laserthermia

CLS erhåller ytterligare garantiåtaganden om cirka 5,8 MSEK för teckningsoptioner av serie TO 7 B 11 nov 2024 09:03

Clinical Laserthermia

The exercise period for CLS warrants of series TO 7 begins today 11 nov 2024 09:00

Clinical Laserthermia

Nyttjandeperioden för CLS teckningsoptioner av serie TO 7 B inleds idag 07 nov 2024 08:30

Clinical Laserthermia

CLS takes next step towards CE marking in neurosurgery by obtaining ISO certificate according to MDR and completion of study at Skåne University Hospital 07 nov 2024 08:30

Clinical Laserthermia

CLS tar nästa steg mot CE-märkning inom neurokirurgi genom erhållet ISO-certifikat enligt MDR samt avslutande av studie vid Skånes Universitetssjukhus 06 nov 2024 10:30

Clinical Laserthermia

New board member of CLS buys shares in the company and the CEO and EVP Operations increase their shareholdings 06 nov 2024 10:30

Clinical Laserthermia

Ny styrelseledamot i CLS köper aktier i bolaget och VD och EVP Operations ökar sina aktieinnehav 31 okt 2024 08:30

Clinical Laserthermia

CLS publicerar delårsrapport januari – september 2024 31 okt 2024 08:30

Clinical Laserthermia

CLS publishes interim report January – September 2024 28 okt 2024 08:30

Clinical Laserthermia

CLS enters subscription undertakings and guarantee commitments for the redemption of warrants of series TO 7 B 28 okt 2024 08:30

Clinical Laserthermia

CLS ingår teckningsförbindelseavtal samt garantiåtaganden för inlösen av teckningsoptioner av serie TO 7 B 23 okt 2024 11:00

Clinical Laserthermia

CLS focus entirely on its successful neurosurgery business positioning the company for sustainable high-margin growth with a more streamlined operation 23 okt 2024 11:00

Clinical Laserthermia

CLS fokuserar helt på sin framgångsrika neurokirurgiska verksamhet och positionerar bolaget för hållbar tillväxt med hög marginal och en mer strömlinjeformad verksamhet 21 okt 2024 11:45

Clinical Laserthermia

Kommuniké från extra bolagsstämma fredagen den 21 oktober i Clinical Laserthermia Systems AB 21 okt 2024 11:45

Clinical Laserthermia

Bulletin from the Extraordinary General Meeting on 21st of October in Clinical Laserthermia Systems AB 02 okt 2024 10:40

Clinical Laserthermia

CLS tidigarelägger publicering av delårsrapport för tredje kvartalet 2024 och bjuder in till webcast 02 okt 2024 10:40

Clinical Laserthermia

CLS reschedules the publication of the Q3 2024 interim report to an earlier date and invites to a webcast 09 sep 2024 14:10

Clinical Laserthermia

Notice of Extraordinary General Meeting at Clinical Laserthermia Systems 09 sep 2024 14:10

Clinical Laserthermia

Kallelse till extra bolagsstämma i Clinical Laserthermia Systems AB 09 sep 2024 14:00

Clinical Laserthermia

CLS meddelar förslag till förändringar i styrelsen 09 sep 2024 14:00

Clinical Laserthermia

CLS announces proposal for changes to the Board of Directors 28 aug 2024 08:53

Clinical Laserthermia

BioStock: CLS prioriterar neurokirurgi över urologi 23 aug 2024 15:30

Clinical Laserthermia

Correction: Publication of CLS half-year report, 1 June – 30 June 2024 23 aug 2024 15:30

Clinical Laserthermia

Rättelse: Offentliggörande av CLS halvårsrapport, 1 juni – 30 juni 2024 23 aug 2024 08:51

Clinical Laserthermia

CLS publishes half-year report January – June 2024 23 aug 2024 08:50

Clinical Laserthermia

CLS publicerar halvårsrapport januari – juni 2024 12 jul 2024 08:30

Clinical Laserthermia

CLS meddelar sista dag för handel med BTU och första dag för handel med teckningsoptioner av serie TO 7 12 jul 2024 08:30

Clinical Laserthermia

CLS announces last day of trading with BTU and first day of trading in warrants of series TO 7 28 jun 2024 16:50

Clinical Laserthermia

CLS offentliggör utfall i företrädesemission 28 jun 2024 16:50

Clinical Laserthermia

CLS announces outcome of rights issue 28 jun 2024 16:10

Clinical Laserthermia

Kommuniké från årsstämma fredagen den 28 juni i Clinical Laserthermia Systems AB 28 jun 2024 16:10

Clinical Laserthermia

Communique from the Annual General Meeting on Friday June 28th in Clinical Laserthermia Systems AB 25 jun 2024 08:30

Clinical Laserthermia

CLS enters the Italian market for Focal Laser Ablation together with the Nationwide Italian Company Tecnogamma s.r.l.25 jun 2024 08:30

Clinical Laserthermia

CLS går in på den italienska marknaden för fokal laserablation tillsammans med det rikstäckande italienska företaget Tecnogamma s.r.l.24 jun 2024 08:30

Clinical Laserthermia

Rekryteringen av patienter med glioblastom till den CLS-sponsrade kliniska studien vid Skåne Universitetssjukhus är nu avslutad 24 jun 2024 08:30

Clinical Laserthermia

Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now Completed 20 jun 2024 14:00

Clinical Laserthermia

Clinical Laserthermia Systems offentliggör tillägg till prospekt avseende pågående företrädesemission 20 jun 2024 14:00

Clinical Laserthermia

Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue 20 jun 2024 08:30

Clinical Laserthermia

CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million 20 jun 2024 08:30

Clinical Laserthermia

CLS erhåller ytterligare order på ClearPoint Prism produkter motsvarande ca 7,5 MSEK 19 jun 2024 15:35

Clinical Laserthermia

Rättelse: Clinical Laserthermia Systems erhåller ytterligare teckningsåtaganden i pågående företrädesemission av units 19 jun 2024 14:27

Clinical Laserthermia

Clinical Laserthermia Systems erhåller ytterligare teckningsåtaganden i pågående företrädesemission av units 17 jun 2024 08:45

Clinical Laserthermia

BioStock: CLS emission finansierar fortsatt marknadsetablering 12 jun 2024 08:50

Clinical Laserthermia

Clinical Laserthermia Systems erhåller teckningsåtaganden, ändrar bedömning av framtida kapitalbehov samt justerar intäkter i prospekt gällande förestående företrädesemission av units 10 jun 2024 17:00

Clinical Laserthermia

CLS publishes prospectus in connection with forthcoming rights issue 10 jun 2024 17:00

Clinical Laserthermia

CLS offentliggör prospekt i samband med förestående företrädesemission 07 jun 2024 21:10

Clinical Laserthermia

Clinical Laserthermia Systems publicerar årsredovisningen för 2023 07 jun 2024 21:10

Clinical Laserthermia

Clinical Laserthermia Systems publishes annual report for 2023 05 jun 2024 17:18

Clinical Laserthermia

BioStock: CLS’ partner initiates full market release in the US 05 jun 2024 17:18

Clinical Laserthermia

BioStock: CLS partner inleder full marknadslansering i USA 05 jun 2024 15:00

Clinical Laserthermia

First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024